Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy
Public ClinicalTrials.gov record NCT01185145. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study of Accelerated Partial Breast Radiotherapy With Either a Novel Breast Brachytherapy Technique - Mammosite or Intensity Modulated Radiotherapy
Study identification
- NCT ID
- NCT01185145
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Rocky Mountain Cancer Centers
- Other
- Enrollment
- 291 participants
Conditions and interventions
Conditions
Interventions
- Breast Brachytherapy with Mammosite RTS Radiation
- Intensity Modulated Radiotherapy Radiation
Radiation
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2004
- Primary completion
- Jul 31, 2014
- Completion
- Jul 31, 2024
- Last update posted
- Jul 10, 2013
2004 – 2024
United States locations
- U.S. sites
- 6
- U.S. states
- 1
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rocky Mountain Cancer Centers - Aurora | Aurora | Colorado | 80012 | — |
| Rocky Mountain Cancer Centers - Boulder | Boulder | Colorado | 80303 | — |
| Rocky Mountain Cancer Centers - Midtown | Denver | Colorado | 80128 | — |
| Rocky Mountain Cancer Centers - Littleton | Littleton | Colorado | 80120 | — |
| Rocky Mountain Cancer Centers - Sky Ridge | Lone Tree | Colorado | 80124 | — |
| Rocky Mountain Cancer Centers - Thornton | Thornton | Colorado | 80260 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01185145, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 10, 2013 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01185145 live on ClinicalTrials.gov.